WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engisch, K. L.
Right arrow Articles by Nowycky, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engisch, K. L.
Right arrow Articles by Nowycky, M. C.

 Previous Article  |  Next Article 

The Journal of Neuroscience, May 1, 1999, 19(9):3384-3395

Lambert-Eaton Antibodies Inhibit Ca2+ Currents But Paradoxically Increase Exocytosis during Stimulus Trains in Bovine Adrenal Chromaffin Cells

Kathrin L. Engisch1, Mark M. Rich2, Noah Cook1, and Martha C. Nowycky1

1 Department of Neurobiology and Anatomy, Medical College of Pennsylvania and Hahnemann University, Philadelphia, Pennsylvania 19129, and 2 Department of Neuroscience, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disease that affects neurotransmitter release at peripheral synapses. LEMS antibodies inhibit Ca2+ currents in excitable cells, but it is not known whether there are additional effects on stimulus-secretion coupling. The effect of LEMS antibodies on Ca2+ currents and exocytosis was studied in bovine adrenal chromaffin cells using whole-cell voltage clamp in perforated-patch recordings. Purified LEMS IgGs from five patients inhibited N- and P/Q-type Ca2+ current components to different extents. The reduction in Ca2+ current resulted in smaller exocytotic responses to single depolarizing pulses, but the normal relationship between integrated Ca2+ entry and exocytosis (Engisch and Nowycky, 1996) was preserved. The hallmark of LEMS is a large potentiation of neuromuscular transmission after high-frequency stimulation. In chromaffin cells, stimulus trains can induce activity-dependent enhancement of the Ca2+-exocytosis relationship. Enhancement during trains occurs most frequently when pulses are brief and evoke very small amounts of Ca2+ entry (Engisch et al., 1997). LEMS antibody treatment increased the percentage of trains eliciting enhancement through two mechanisms: (1) by reducing Ca2+ entry and (2) through a Ca2+-independent effect on the process of enhancement. This leads to a paradoxical increase in the amount of exocytosis during stimulus trains, despite inhibition of Ca2+ currents.

Key words: exocytosis; chromaffin cell; capacitance detection; Ca2+-secretion coupling; Lambert-Eaton myasthenic syndrome; facilitation


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Patients with the Lambert-Eaton myasthenic syndrome (LEMS) have a defect in neuromuscular transmission, thought to be caused by antibody-mediated downregulation of presynaptic calcium channels (Vincent et al., 1989; Engel, 1991; Sher et al., 1993; Lennon et al., 1995). There are two primary changes in neuromuscular function in LEMS (Elmqvist and Lambert, 1968; Cull-Candy et al., 1980): (1) reduction of release evoked by a single stimulus and (2) unusual facilitation during repetitive stimulation. These behaviors are reminiscent of endplate potentials (EPPs) recorded under conditions of low external Ca2+ ([Ca2+]o) and/or high [Mg2+]o (for review, see Magelby, 1987). Facilitation is traditionally attributed to Ca2+ accumulation during the stimulus train (Katz and Miledi, 1968). By analogy it has been suggested that facilitation in LEMS is also caused by Ca2+ accumulation (Lambert and Elmqvist, 1971; Tim and Sanders, 1994; Maddison et al., 1998).

In addition to inhibition of motor nerve terminal Ca2+ currents (Smith et al., 1995), LEMS antibodies disrupt the regular arrangement of active zone particles (Fukunaga et al., 1982; Engel, 1991). Loss or disorganization of active zones could affect the Ca2+ dependence of neurotransmitter release. Ca2+-dependent exocytosis might also be impaired if other synaptic proteins, such as synaptotagmin, are targets of LEMS antibodies [Takahashi et al. (1991); Leveque et al. (1992); Yoshida et al. (1992); Takamori et al. (1994, 1995); Charvin et al. (1997); but see Hajela and Atchison (1995)].

The adrenal chromaffin cell is frequently used for studies of Ca2+-secretion coupling (Trifaro et al., 1993; Morgan and Burgoyne, 1997; Burgoyne and Morgan, 1998). Changes in membrane capacitance can be used in these cells to monitor exocytosis of large dense-cored vesicles (Neher and Marty, 1982). We have shown previously that in perforated-patch recordings, exocytosis evoked by single depolarizations is a function of integrated Ca2+ entry, raised to the ~1.5 power (Engisch and Nowycky, 1996). During repetitive stimulation, chromaffin cells display activity-dependent behaviors, such as increases in the Ca2+-exocytosis relationship ("enhancement") or decreases in the Ca2+-exocytosis relationship ("depression") (Engisch et al., 1997).

LEMS antibodies inhibit Ca2+ currents in bovine chromaffin cells (Kim and Neher, 1988; Viglione et al., 1992; Blandino and Kim, 1993) but have no effect on exocytosis elicited by intracellular perfusion with buffered Ca2+ solutions (Kim and Neher, 1988). This suggests that LEMS antibodies do not act directly on the Ca2+-dependent fusion machinery. However, the effect of LEMS antibodies on exocytosis evoked by depolarization-induced Ca2+ entry is not known. Simple inhibition of Ca2+ channels with Ca2+ channel toxins in chromaffin cells does not change the Ca2+ dependence of exocytosis evoked by single pulses (Engisch and Nowycky, 1996). On the other hand, small Ca2+ current integrals are more likely to induce enhancement during stimulus trains (Engisch et al., 1997). Effects of LEMS antibodies on neurotransmission may be caused entirely by inhibition of Ca2+ currents, or there may be additional actions of LEMS antibodies on stimulus-secretion coupling. To examine these possibilities we treated bovine adrenal chromaffin cells with five LEMS IgGs and determined Ca2+-exocytosis relationships during single pulses and stimulus trains.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Chromaffin cell culture. Adrenal chromaffin cells were prepared from adult bovine adrenal glands by collagenase digestion (0.02%) and purification on a Percoll gradient (Pharmacia, Piscataway, NJ), as described in Vitale et al. (1991). Cells were plated on 12-mm-diameter collagen-coated glass coverslips (8.4 × 104 cells/coverslip) in a culture medium consisting of DMEM, supplemented with 25 mM HEPES, 10% fetal bovine serum (FBS), antibiotics (penicillin, 0.01%; streptomycin, 0.01%; and gentamycin, 0.001%), and mitotic inhibitors (cytosine arabinoside, 10 µM; fluoro-deoxyuridine, 10 µM). Cells were used between day 3 and day 7 in vitro and were fed on day 3 and day 6.

Purification of LEMS antibodies. IgGs were purified by running human sera over a protein G column (Pharmacia, Piscataway, NJ) and eluting the bound IgG molecules according to the manufacturer's instructions. IgGs were concentrated in Dulbecco's PBS to stock concentrations of 50-100 mg/ml by centrifugation in a 10 kDa cutoff Centricon (Amicon, Beverly, MA). IgG concentrations were determined using the Lowry method, with bovine serum albumin as a standard. It was assumed that all protein in the purified sample was IgG. Stocks and sera were kept frozen at -80°C. Care was taken not to subject IgGs to more than two freeze-thaw cycles.

Treatment of chromaffin cell cultures with purified IgG. Stock IgG was added to individual cultures at a final concentration of 1-2 mg/ml. Typically 4-8 µl of stock solution was added to a culture well containing 400 µl of culture medium. Cells were assayed after 24 or 48 hr of incubation in IgG. For a 48 hr treatment, fresh stock IgG was added to the culture 24 hr after the initial addition. At most, two IgGs were tested on cells from a single culture (culture = cells from one bovine adrenal gland), and cells in untreated dishes of the same culture served as controls. IgGs from non-disease subjects were tested in the same way, with untreated cells from the same culture as controls. Each IgG was tested on cells from a minimum of three cultures (range, three to seven cultures). No dramatic differences were observed between 24 or 48 hr IgG incubations, or between 1 or 2 mg/ml IgG, so these data have been pooled in the final analysis. The majority of data were obtained using 1 mg/ml for 48 hr.

Electrophysiological solutions and recording conditions. Individual glass coverslips were transferred to a chamber perfused with extracellular recording solution at a rate of 1-2 ml/min. Extracellular solution contained (in mM): 130 NaCl, 2 KCl, 10 glucose, 10 Na-HEPES, 1 MgCl2, 5 N-methyl-D-glucamine, and 5 CaCl2, pH adjusted to 7.2 with HCl; 295 mOsm. Experiments were performed at room temperature (21-26°C).

Perforated-patch intracellular solution contained (in mM): 135 Cs-glutamate, 10 HEPES (pKa 7.5) or 10 morpholino propane sulfonic acid (pKa 7.2), 9.5 NaCl, and 0.5 Na4BAPTA (pH adjusted to 7.2 with CsOH, 305-310 mOsm, adjusted with mannitol). Amphotericin B was included in the pipette solution as follows. Amphotericin B was prepared as a stock solution (125 mg/ml) in dimethyl sulfoxide (DMSO) by sonication and was kept in the dark at room temperature for up to 2 hr. Stock amphotericin B solution was added to intracellular solution at a final concentration of 0.5 mg/ml and dispersed by homogenization with a Pro-250 Homogenizer (Pro Scientific, Monroe, CT) for 5-10 sec. Because amphotericin B interferes with seal formation, patch pipettes were pre-dipped (10-15 sec) in amphotericin B-free intracellular solution and backfilled with amphotericin B-containing solution.

CsOH was obtained from ICN Biochemicals (Aurora, OH), amphotericin B and glutamic acid were from Calbiochem (La Jolla, CA), Na4BAPTA was from Molecular Probes (Eugene, OR), and DMSO was from Aldrich (Milwaukee, WI). Culture media and PBS were purchased from Life Technologies (Grand Island, NY). Collagenase was obtained from Worthington (Lakewood, NJ), and FBS was from Biocell (Rancho Dominquez, CA). All other chemicals were purchased from Sigma (St. Louis, MO).

Capacitance detection. Capacitance measurements were performed in perforated-patch whole-cell voltage-clamp recordings using a modified List EPC-7 patch-clamp amplifier and a software-based phase-tracking algorithm (Joshi and Fernandez, 1988; Fidler and Fernandez, 1989). A sine wave stimulus (40 mV peak-to-peak amplitude, 1400 Hz) was added to a holding potential of -90 mV. Orthogonal phase angles for measuring capacitance and conductance were calculated at the beginning of each capacitance trace (trace = 18 sec) by measuring changes in sine wave current produced by transiently connecting a 500 kOmega resistor in series with ground. Ten sine waves were averaged for each capacitance and conductance point. The time resolution was 18 msec/point (486 IBM clone personal computer). Data acquisition was initiated when the access conductance increased to 70 nS. Capacitance changes were calibrated by electronic displacement of 100 fF in the capacitance compensation circuitry of the patch clamp. The amplitude of a stimulus-evoked membrane capacitance (Cm) increase was determined from the difference between a 10 point average (~180 msec) before depolarization and the 10 point average after return to capacitance recording after the depolarizing stimulus. Cells were stimulated every 2 min to allow complete recovery of Ca2+ currents from inactivation. Often the Cm response after a large Ca2+ load (stimulus train or long duration pulse) was larger than expected from the single pulse Ca2+-exocytosis relationship, even with a 2 min interval between protocols. Therefore, as described previously, a single 40 msec depolarization was always applied after such a stimulus and the response was discarded from analyses (Engisch and Nowycky, 1996).

Analysis of Ca2+ currents. Chromaffin cells were stimulated with depolarizations from a holding potential of -90 mV to a test potential of +20 mV, unless noted otherwise. Pulse duration was varied as indicated in the text and figure legends. Ca2+ entry, in picocoulombs, was calculated from integration of inward current, using limits that excluded the major portion of Na+ current. Sampling rate was 50 kHz for 5 msec pulses, 20 kHz for 10 and 40 msec pulses, 5 kHz for 160 msec pulses, and 2.5 kHz for 320 msec pulses; all currents were filtered at 3 kHz. Tetrodotoxin was not included in the extracellular recording solution because of its slowing effect on the Na+ channel-gating current that can contribute to depolarization-induced capacitance increases unrelated to exocytosis (Horrigan and Bookman, 1993; Chow et al., 1996). Current traces were leak-subtracted before integration and amplitude measurements. End current amplitude (an estimate of "P/Q-type" current) was determined from an average of 20 points immediately preceding termination of the voltage pulse. Difference current amplitude (an estimate of "N-type" current) was calculated from the difference between the peak current (cursor value at peak located by experimenter) and the end current. Differences in Ca2+ current amplitudes and integrals were assessed using Student's t test (independent, unless noted otherwise).

Derivation of standard curve. The standard curve depicted in Figures 3-5 and 8 represents the average relationship between Ca2+ entry and amount of exocytosis, or capacitance increase, for single depolarizations. It was derived by averaging input-output relationships obtained in 27 cells using single step depolarizations to evoke exocytosis, and different methods to vary Ca2+ entry (changing duration or test potential, perfusion with a range of extracellular Ca2+ concentrations, or application of Ca2+ channel toxins.) Plots of exocytosis as a function of the integral of the Ca2+ current were fit with the function: Delta Cm = g × (QCa)n, where Delta Cm is the amount of exocytosis in femtofarads, QCa is the integral of the Ca2+ current in picocoulombs, raised to the nth power, and g is a proportionality constant; g and n were varied until chi 2 reached a minimum value (Marquardt-Levenberg algorithm in Origin; Microcal, Northampton, MA). The curves from 27 cells were averaged to generate the standard curve, which was fit with g = 0.147 and n = 1.49.

Classification of Ca2+-exocytosis relationships during stimulus trains. Exocytosis evoked by a train of depolarizing pulses (-90 mV to + 20 mV), 200 msec between pulses, was analyzed by summing exocytosis evoked by each successive pulse to generate a cumulative response. Pulse duration was 5 msec (typically 35 pulses in a train), 10 msec (30 pulses), or 40 msec (20 pulses). The cumulative exocytotic response was plotted as a function of cumulative Ca2+ entry, calculated by integrating each inward current and summing for all the pulses in the train.

Classifications of enhancement or depression of the Ca2+-exocytosis relationship were made when the amount of exocytosis during a train was larger or smaller, respectively, than that predicted by the single-pulse standard curve. A response was classified as "enhanced" if the amount of exocytosis was >1.6× the expected value (from standard curve) and as "depressed" if the amount of exocytosis evoked by the train was <0.8× the expected value [see also Engisch et al. (1997)]. A relationship was classified as "standard" if it fell between these boundaries. Differences between distributions of secretory behaviors were assessed using Pearson's chi 2 test.

Definitions of "other" secretory behaviors. After antibody treatment, trains in several cells evoked unusual secretory behaviors (Table 1) that could not be classified into enhanced, standard, or depressed categories as defined in a previous study (Engisch et al., 1997). "Endocytosis" during a train was characterized by a negative slope of capacitance. A "docked" response had very large Cm increases early in the train (far in excess of the amount expected based on the standard Ca2+-exocytosis relationship); after several pulses there was a rapid decline or cessation of exocytosis. This type of behavior has been observed at the beginning of conventional whole-cell recordings before wash out (Seward and Nowycky, 1996). A "delayed" response fell below the standard relationship initially, with significant exocytosis occurring late in the train. This behavior resembles the "threshold" secretory response that occurs late in the recording period in conventional whole-cell experiments (Seward and Nowycky, 1996).


                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Unusual responses evoked by stimulus trains in cells treated with LEMS IgGs


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Clinical findings in five LEMS patients

LEMS was diagnosed based on amplitude of the compound muscle action potential (CMAP) in abductor pollicus brevis muscles. CMAPs measured at rest (initial CMAP) and immediately after 15 sec of voluntary contraction (post-exercise) are given in Table 2 for the five LEMS patients in this study.


                              
View this table:
[in this window]
[in a new window]
 
Table 2.   LEMS patient data

Both N- and P/Q-type Ca2+ currents are inhibited by LEMS antibodies

Ca2+ currents recorded in perforated-patch mode in adult bovine adrenal chromaffin cells are carried primarily by two subtypes of Ca2+ channels, which can be kinetically distinguished during prolonged (320 msec) depolarizations (Engisch and Nowycky, 1996). A rapidly inactivating current component is inhibited by 1 µM omega -conotoxin GVIA (Fig. 1Ai,B). The plateau current (the current remaining at the end of the pulse) is more sensitive to 1 µM omega -agatoxin IVA (Fig. 1Aii,C). Greater inhibition of each current component is observed when both toxins are applied together than when a single toxin is applied (Fig. 1B,C). This probably reflects the imperfect separation of the inactivating and noninactivating components at a duration of 320 msec. However, omega -agatoxin IVA does not significantly affect the inactivating component, and omega -conotoxin GVIA does not inhibit the plateau component (Fig. 1B,C). For convenience we will refer to the conotoxin-sensitive component as N-type and the agatoxin-sensitive component as P/Q-type, although it is becoming clear that toxin sensitivity is not a sufficient criterion for classifying this complex family (for review, see Randall, 1998). L-type channels, including the facilitation Ca2+ channel (Artalejo et al., 1990, 1991a,b), do not contribute significantly to whole-cell Ca2+ currents in adult bovine adrenal chromaffin cells (Chow et al., 1996; Engisch and Nowycky, 1996; Elhamdani et al., 1998).



View larger version (21K):
[in this window]
[in a new window]
 
Figure 1.   Pharmacological and kinetic dissection of inward current in adult bovine adrenal chromaffin cells. Ai, Perfusion with 1 µM omega -conotoxin GVIA selectively inhibits the peak inward current evoked by a 320 msec depolarization from -90 to +20 mV. Aii, Perfusion with 1 µM omega -agatoxin IVA almost completely inhibits inward current measured at the end of a 320 msec voltage step (different cell from i). Aiii, Plateau current is measured at the end of a 320 msec voltage step. Difference current is obtained by subtracting this amount from the peak inward current. In this and subsequent figures, the first rapid inward current component is the Na+ current. B, Amplitude of the difference current for cells before toxin application (control) or after perfusion or preincubation in 1 µM the indicated toxins, alone or together (both). A remaining component of difference current after application of both toxins may be carried by another calcium channel subtype. Numbers above bars indicate number of cells. C, Amplitude of the plateau current for cells before and after exposure to calcium channel toxins. Although omega -conotoxin does not significantly inhibit the plateau current when applied alone, there is an additive effect when the toxins are co-applied, suggesting that some overlap of channel subtypes contribute to this component. Data from the same cells as in B.

Total Ca2+ entry integrated over a 320 msec depolarization was significantly inhibited by treatment with four of five Lambert-Eaton IgGs (Fig. 2A). Inhibition of Ca2+ entry by LEMS IgGs varied in magnitude, with a maximum block of 39% (LEMS 3). One IgG (LEMS 4) did not inhibit total Ca2+ entry nor did treatment with IgGs from subjects without LEMS (IgG; data for two control IgGs pooled).



View larger version (45K):
[in this window]
[in a new window]
 
Figure 2.   Inhibition of total integrated Ca2+ entry, and N- and P/Q-type Ca2+ current components, by five LEMS IgGs. A, Total Ca2+ entry, integrated over a 320 msec depolarizing voltage step from -90 mV to +20 mV, for untreated cells in sister cultures (None); cells treated with IgG from non-disease controls (IgG; data pooled for cells treated with either of two control IgGs); and cells from five patients with LEMS. Integration excludes the first rapid inward current component, which is carried by Na+ ions. The number of cells is at least eight for each bar. Right, Superimposed inward current traces evoked by a 320 msec voltage step for a cell treated with non-disease IgG (Norm IgG, thin line) and for another treated with LEMS 4 IgG (thick line). Cells were treated with 1 or 2 mg/ml IgG for either 24 or 48 hr (see Materials and Methods). B, Amplitude of the difference current (see Fig. 1Aiii for description of kinetic components) for IgG-treated cells and cells in untreated sister cultures. Right, Inward current trace evoked by a 320 msec depolarization in a cell treated with LEMS 3 IgG (thick line), illustrating inhibition of both peak and plateau current, compared with same Norm IgG trace (thin line) as shown in A. C, Plateau current amplitude for same cells as in B. Right, Inward current evoked by 320 msec depolarization in a cell treated with LEMS 5 IgG (thick line), illustrating strong inhibition of plateau current with little effect on peak current. Norm IgG, Current trace same as in A and B (thin line). *p < 0.05 (Student's t test), compared with untreated controls.

To determine the subtypes of Ca2+ channels affected by Lambert-Eaton IgGs, we used the kinetic and pharmacological dissection described in Figure 1. Two of the five patient IgGs, LEMS 1 and LEMS 3, significantly reduced the N-type current component compared with values obtained in untreated cells from sister dishes in the same cultures (Fig. 2B, None). The N-type component is also slightly smaller in cells treated with control IgGs, but this difference was not significantly different from the average in untreated cells. In addition, a paired Student's t test between responses of treated and untreated cells on matching experimental days was not significant (p > 0.4; n = 7 pairs). In contrast, a paired Student's t test between values for LEMS1-treated cells and untreated cells from matching experimental days was highly significant (p < 0.01; n = 7 pairs). The responses of control IgG-treated cells and LEMS IgG-treated cells were not compared directly because the data were obtained in separate experiments. The maximum percentage reduction in N-type current was only ~24% (458 ± 41 pA, LEMS 1, vs 602 ± 30 pA, untreated cells).

Every patient IgG tested, including LEMS 4, significantly inhibited the P/Q-type current (Fig. 2C). Maximum inhibition was 52% (74 ± 9 pA, LEMS 5, vs 156 ± 7 pA, untreated cells). Inhibition of P/Q-type current by LEMS 4 was only 17%. In chromaffin cells the N-type component is a much greater fraction of the total current, which may explain why the effect of LEMS 4 IgG did not reach statistical significance for total Ca2+ entry (Fig. 2A).

The heterogeneous effects of LEMS IgGs on Ca2+ channels are consistent with most previous reports (Kim and Neher, 1988; Blandino and Kim, 1993; Grassi et al., 1994; Blandino et al., 1995; Viglione et al., 1995; Garcia and Beam, 1996; Garcia et al., 1996; Magnelli et al., 1996; Meriney et al., 1996). Here we show that IgG from a single patient (LEMS 1 and LEMS 3) can act on two calcium channel subtypes (Fig. 2B,C). On the other hand, an individual patient IgG can very specifically target a single Ca2+ current component. LEMS 5 strongly inhibited the P/Q-type component (Fig. 2C, right), similar to the application of 1 µM agatoxin IVA (Fig. 1Aii), but had no effect on the N-type current component (Fig. 2B). The more consistent inhibition of the P/Q-type current component is in agreement with binding studies showing that >80% of Lambert-Eaton patients have high anti-P/Q titers, whereas only 40% have high anti-N titers (Lennon et al., 1995; Motomura et al., 1997).

There was a correspondence between Ca2+ current inhibition by LEMS IgGs in chromaffin cells and the severity of the disease, based on measurements of the initial CMAP (Table 2). Total Ca2+ entry in chromaffin cells correlated with initial CMAP amplitude (r = 0.89, assuming a value of 7 mV for control and normal IgG) (Kimura, 1989). This correlation appears to be attributable to effects on the P/Q-type Ca2+ channel, because the r value for P/Q-type current amplitude versus initial CMAP amplitude was 0.88 but for N-type Ca2+ the current amplitude was 0.30.

LEMS antibodies do not change the basal Ca2+-exocytosis relationship observed during single step depolarizations

In perforated-patch recordings of adult bovine adrenal chromaffin cells, exocytosis evoked by single step depolarizations has a simple but nonlinear dependence on integrated Ca2+ entry (Engisch and Nowycky, 1996; Engisch et al., 1997) (see Materials and Methods): Delta Cm = g × (QCa)n, where Delta Cm is the increase in membrane capacitance, QCa is the integral of the Ca2+ current in picocoulombs, g is a proportionality constant, and n is the power (Engisch et al., 1997). For the average curve, which we will refer to as the standard Ca2+-exocytosis relationship, g = 0.147 and n = 1.49. This relationship has been plotted as a dashed curve in Figures 3-5 and 8.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 3.   Exocytosis evoked by single depolarizing voltage pulses in a control and a LEMS 3-treated cell. A, Cm changes in response to single step depolarizations from -90 mV to the indicated test potentials (Test Pot), for a control (untreated) cell and a cell incubated in 1 mg/ml LEMS 3 IgG for 24 hr. Gaps indicate the timing of the depolarization, when capacitance recording is suspended. Below, Inward currents evoked by the depolarizations; numbers indicate relevant Cm trace. B, Cm responses evoked by 160 msec depolarizations to different test potentials, plotted as a function of integrated Ca2+ entry, for the cells illustrated in A. LEMS 3 IgG indicated by black-square; untreated control cell from the same culture indicated by . The data cluster near the standard curve (dashes), a representation of the average relationship during single pulses for adrenal chromaffin cells (see Materials and Methods). The numbers adjacent to data points correspond to the numbered traces in A.

To determine whether the single-pulse Ca2+-exocytosis relationship was affected by LEMS antibodies, exocytosis was evoked by single depolarizations. Pulse duration or test potential was varied to sample a range of Ca2+ entry values. In an untreated chromaffin cell, single depolarizations evoked larger capacitance increases than the same voltage steps in a cell treated with LEMS 3 IgG (Fig. 3A; Control: 1, 2; LEMS 3: 3, 4). The relationship between integrated Ca2+ entry (QCa) and amount of exocytosis (Delta Cm) is shown in Figure 3B for the two cells. Both sets of data lie close to the standard input-output relationship (dashed curve), indicating that the Ca2+ dependence of exocytosis was not altered by treatment with LEMS 3 IgG. All values in the LEMS 3-treated cell were simply shifted down the input-output relationship to a region of small responses.

Similar experiments were performed in cells treated with five different LEMS IgGs and IgGs from non-disease controls. Responses were binned by Ca2+ current integrals and averaged for each IgG (Fig. 4). A plot of the standard Ca2+-exocytosis relationship (dashed curve) is overlaid on the data. The average responses in IgG-treated cells lie close to the standard curve, regardless of which channel type(s) was affected. In summary, five LEMS IgGs that differentially affect N- and P/Q-Ca2+ channel subtypes reduce exocytosis but do not change the single-pulse Ca2+-exocytosis relationship.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 4.   The relationship between exocytosis and integrated Ca2+ entry for single depolarizing pulses is unchanged after treatment with control or LEMS IgGs. Cm increases evoked by single depolarizing pulses (40-320 msec in duration, -90 to +20 mV) were binned by amount of Ca2+ entry for cells treated with IgG from non-disease controls (Normal IgG) and five LEMS patients (bin ranges: below 16 pC, 16-32 pC, 33-48 pC, 49-80 pC, above 80 pC). Two of the IgGs inhibit Ca2+ entry to such an extent that only four ranges of Ca2+ entry are represented (LEMS 3, LEMS 5). The points are overlaid on the standard curve (dashes) for comparison purposes. Each point is the average of at least eight measurements, except for the values at the largest Ca2+ entry bin for LEMS 1 and LEMS 7, which are the average of only five measurements.

LEMS antibodies promote activity-dependent enhancement during stimulus trains

The key diagnostic feature of the Lambert-Eaton myasthenic syndrome is a large potentiation of neuromuscular transmission after high-frequency repetitive stimulation (Table 2). We have previously described two types of modulation of the Ca2+-exocytosis relationship that can occur in bovine chromaffin cells during repetitive stimulation (Engisch et al., 1997). Some trains evoke exocytosis that has the same relationship with integrated Ca2+ entry as exocytosis stimulated by single pulses (Fig. 5Aii,Bii). Other trains evoke exocytosis that shows potentiation of the Ca2+-exocytosis relationship (Fig. 5Ai,Bi). Trains in a third group evoke much less exocytosis than expected from the single pulse Ca2+-exocytosis relationship and are classified as depressed (Fig. 5Aiii,Biii).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 5.   Examples of secretory behaviors observed during repetitive stimulation in untreated adrenal chromaffin cells. A, Cm changes evoked by stimulus trains of depolarizing pulses (-90 to +20 mV) applied at 200 msec intervals. The timings of the depolarizations are indicated by gaps and vertical lines beneath the traces. Ai, A large increase in Cm evoked by a train of 5 msec pulses. Aii, A smaller Cm increase evoked by a train of 5 msec depolarizations in a different cell. Aiii, In a third cell, a train of 40 msec depolarizations does not evoke substantially greater exocytosis than the train in ii. Insets, Inward currents evoked by the first and last depolarization of each stimulus train. B, Cm increases summed over the stimulus train, plotted as a function of cumulative integrated Ca2+ entry for the traces shown in A. In each panel the dashed curve is the standard single-pulse Ca2+-exocytosis relationship (see Materials and Methods). Bi, The response abruptly shifts to an enhanced Ca2+-exocytosis relationship after seven pulses. Bii, The response maintains the same relationship to integrated Ca2+ entry as the standard curve. Note a similar amount of total Ca2+ entry occurred in this and the cell in i (~60 pC). Biii, The response has a depressed Ca2+-exocytosis relationship, compared with the standard curve. As a result, little exocytosis is evoked despite total Ca2+ entry >150 pC.

In untreated cells the likelihood of obtaining enhancement, depression, or a standard input-output relationship during a stimulus train is correlated with the amount of Ca2+ entry during the first pulse of the train (Engisch et al., 1997). Enhancement was observed in >30% of trains made up of 5 msec pulses (Fig. 6, CONTROL, 5 ms, white section). In contrast, a train of 40 msec pulses usually produced depression (~90% of trains) (Fig. 6, CONTROL, 40 ms, black section), and enhancement was only rarely observed. The distribution of response behaviors for trains of 10 msec pulses was intermediate between that for 5 and 40 msec pulses. In addition, when compared in the same cell, a train of 5 msec pulses was almost always more efficacious than a train of 40 msec pulses, unless the two protocols evoked responses with the same Ca2+-exocytosis relationship (Engisch et al., 1997).



View larger version (28K):
[in this window]
[in a new window]
 
Figure 6.   Enhancement during repetitive stimulation is more likely after treatment with LEMS IgGs. Pie graphs depict the distribution of response behaviors evoked by trains of depolarizing pulses. Control data are from Engisch et al. (1997, their Figs. 1-3), with 78 trains of 5 msec pulses, 42 trains of 10 msec pulses, and 93 trains of 40 msec pulses. LEMS data are from all cells treated with LEMS IgGs, with 44 trains of 5 msec pulses, 45 trains of 10 msec pulses, and 46 trains of 40 msec pulses. Only one train of any particular protocol was included per cell; multiple trains in the same cell were included if the protocols were different. Enhanced (white sections), standard (cross-hatched sections), and depressed (black sections) Ca2+-exocytosis relationships were defined as being above, on, or below the standard single pulse relationship, respectively. A new category, Other, is shown as a striped section (also see Table 1).

We examined whether the reduction in Ca2+ entry caused by treatment with LEMS antibodies would lead to a greater percent of trains with enhancement. We found that the percentage of trains inducing enhancement was increased for all pulse protocols (Fig. 6; compare white sections, CONTROL vs LEMS). A greater proportion of trains with enhancement resulted not only from decreases in the number of depressed responses (black sections) but also from decreases in standard responses (cross-hatched sections). There were some unusual response behaviors after exposure to LEMS antibodies that could not be classified into the categories used for controls, but these were relatively rare (Other, 7-14%; striped sections; for details, see Figure 6 legend and Table 1). In summary, it appears that decreasing Ca2+ entry at any pulse duration led to an increase in the probability of enhancement, at the expense of standard and depressed Ca2+-exocytosis relationships.

A subset of LEMS IgGs promotes activity-dependent enhancement even after effects of Ca2+ current inhibition have been taken into account

We grouped trains by amount of Ca2+ entry, rather than by pulse duration, to compare responses from controls and LEMS-treated cells after normalizing for the effects of LEMS antibodies on Ca2+ currents. This procedure will reveal whether there are any additional changes in activity-dependent behaviors after exposure to LEMS IgGs. We grouped trains into three ranges based on the amount of Ca2+ entry during the first pulse of the train: low, middle, and high.

In the middle and high ranges, data from the five LEMS IgGs were pooled, because the number of trains was insufficient for adequate comparison of results for individual IgGs. In control cells, essentially all trains in the high range (Ca2+ entry >6 × 107 ions or 19 pC) evoked a depressed response [67/68; compare Engisch et al. (1997), their Fig. 4]. Similarly, depression occurred in the vast majority of trains from LEMS-treated cells that fell in the high range (24/25 trains). In the middle range (Ca2+ entry between 2 and 6 × 107 ions, or 6.4 and 19 pC), the percentage of trains with depression was slightly lower in LEMS-treated cells compared with controls (54 vs 69%). These results indicate that the ability of large Ca2+ loads to induce depression is not substantially altered by treatment with LEMS IgGs.

The probability of obtaining enhanced or standard responses was increased as pulse duration was shortened in control cells. The distribution of response behaviors evoked in control cells by stimulus trains within the low range of Ca2+ entry (QCa <2 × 107 ions or 6.4 pC) is illustrated in Figure 7A [Engisch et al. (1997), data reproduced from first two bins of their Fig. 4]. Enhancement, a standard Ca2+-exocytosis relationship, and depression are approximately equally likely, with a slight trend toward enhancement. In this Ca2+ entry range there were sufficient numbers of trains in LEMS-treated cells so that each IgG could be separately examined. The proportion of trains with enhancement was clearly not increased in cells treated with non-LEMS control IgG (Fig. 7B), LEMS 1 (Fig. 7C), or LEMS 5 (Fig. 7F). In cells treated with LEMS 7 there were no depressed responses evoked by trains (Fig. 7G), but because so few depressed responses are expected, this change was not statistically significant. For two of the LEMS IgGs, the distribution of secretory behaviors was different from the expected values. Enhancement was observed in ~70% of the trains in cells treated with LEMS 3 (Fig. 7D) or LEMS 4 (Fig. 7E), almost twice the normal frequency. The shift to greater numbers of trains with enhancement was statistically significant at the 0.05 (LEMS 3) and 0.01 (LEMS 4) levels (Pearson's chi 2 test). Finally, the shifts occurred although average Ca2+ current integrals were not statistically different from the average integral for non-disease control IgG (LEMS 3 IgG, 2.7 ± 0.3 pC; LEMS 4 IgG, 3.2 ± 0.3 pC; normal IgG, 3.5 ± 0.3 pC). Thus, IgGs from a subset of patients appear to make conditions unusually favorable for activity-dependent enhancement, through a mechanism other than inhibition of Ca2+ currents.



View larger version (22K):
[in this window]
[in a new window]
 
Figure 7.   Distribution of secretory behaviors evoked by trains with small amounts of Ca2+ entry for the first pulse of the train. A, Control distribution, taken from Engisch et al. (1997). Low range of Ca2+ entry: QCa < 6.4 pC. Percentage of trains in a large sample (n = 106) with the indicated secretory behaviors. This distribution was used to give expected values for the sample sizes in treated groups. B-F, Number of trains in each category for cells treated with IgGs. There is an unusually large number of enhanced responses in cells treated with LEMS 3 IgG (D) and LEMS 4 IgG (E). LEMS 1, 5, and 7 had normal distributions of secretory behaviors. Other responses were not included in the statistical comparison; the total number of trains was taken after subtracting any Other trains. *p < 0.05, **p < 0.01; Pearson's chi 2 test.

In summary, our data indicate that a chromaffin cell treated with LEMS IgG will have reduced exocytosis in response to a single stimulus, but will be more likely to show activity-dependent enhancement of exocytosis during a train. This situation closely resembles the neuromuscular defect in the Lambert-Eaton myasthenic syndrome. In Figure 8, exocytosis evoked by single depolarizations is compared with exocytosis evoked by a train in an individual chromaffin cell exposed to LEMS 3 IgG. Single 160 msec depolarizations evoked less exocytosis than the stimulus train, when similar amounts of Ca2+ entry were compared. Thus, during repetitive stimulation a reduction in Ca2+ entry by LEMS antibodies does not necessarily lead to a decrease in exocytosis. Instead there may be a paradoxical increase in the amount of release attributable to the occurrence of activity-dependent enhancement.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 8.   Comparison of single pulse responses with a train-evoked response in a LEMS 3-treated chromaffin cell. A, Membrane capacitance trace (Cm) recorded during repetitive stimulation with 5 msec depolarizing voltage steps (-90 to +20 mV) in a cell that had been treated for 24 hr with LEMS 3 IgG (1 mg/ml; same cell as in Fig. 3). The inward currents evoked by the first and last depolarization of the train are illustrated below (ICa). B, Cm increases evoked by the stimulus train in A () and single 160 msec depolarizations to different test potentials (black-square; -5, 0, and +20 mV test pulses from Fig. 3 plotted versus integrated Ca2+ entry. The dashed curve is the standard single pulse Ca2+-exocytosis relationship (see Materials and Methods).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

We studied the effect of LEMS IgGs on Ca2+ currents and depolarization-evoked exocytosis in bovine adrenal chromaffin cells. Three IgGs inhibited only P/Q-type Ca2+ current, and two additionally affected N-type Ca2+ current, in agreement with studies suggesting that LEMS antibodies can target multiple sites (Johnston et al., 1994; Takamori et al., 1997; Katz et al., 1998; Verschuuren et al., 1998) (also see Results). Our findings disagree with the suggestion that N-type calcium channels are not functionally affected by LEMS antibodies (Pinto et al., 1998). There are several possible reasons for the difference in results. First, the effect we observe was confined to two of five IgGs tested. Second, the small effect on N-type Ca2+ current (maximum 24%) might have been missed in the K+-stimulated [Ca2+]i measurements used by Pinto et al. (1998). In any case, the effect on P/Q-type Ca2+ current appears to be responsible for the clinical deficits. Total Ca2+ entry and P/Q-type current amplitude roughly correlated with the size of CMAPs in the five LEMS patients, whereas N-type current amplitude did not. These results suggest that the P/Q type Ca2+ channels inhibited by LEMS in chromaffin cells are similar to the P/Q-type Ca2+ channels mediating human neuromuscular transmission (Protti et al., 1996). Examining the effects of LEMS antibodies on Ca2+-secretion coupling in chromaffin cells may give us insights into the underlying mechanism of the neuromuscular disease.

Small initial CMAPs in LEMS may be attributable to the reduction in Ca2+ channel number, but active zones are disorganized in the disease (Engel, 1991), and this or other effects of the antibodies could alter the Ca2+ dependence of release. At the neuromuscular junction (NMJ) the Ca2+ dependence of transmitter release must be inferred from the relationship between postsynaptic responses and extracellular Ca2+ concentration ([Ca2+]o). Neurotransmitter release at the NMJ increases as the third or fourth power of [Ca2+]o, at very low [Ca2+]o or high [Mg2+]o (Dodge and Rahamimoff, 1967; Hubbard et al., 1968; Cooke et al., 1973; Cull-Candy et al., 1976). A reduction in the number of Ca2+ channels at the terminal should leave the power unchanged but shift the relationship to the right, because higher levels of [Ca2+]o are required to evoke the same amount of release. The power of the relationship between [Ca2+]o and release at LEMS patient NMJs appeared to be decreased to ~1.5 (Cull-Candy et al., 1980). Although the authors concluded that LEMS is associated with a lower Ca2+ sensitivity of the release process, the 1.5-power relationship was probably the result of focusing on the physiological range of Ca2+ and Mg2+ concentrations in that study. In experiments in high [Mg2+]o at the mouse NMJ after passive transfer of LEMS, a power dependence of 3.9 was observed, and the relationship between endplate potentials and [Ca2+]o was indeed shifted to the right (Lang et al., 1987).

The dependence of transmitter release on Ca2+ influx, rather than [Ca2+]o, cannot be directly examined at the NMJ because it is difficult to measure Ca2+ currents in the motorneuron terminal. This question can be addressed in control and LEMS-treated bovine adrenal chromaffin cells. Exocytotic responses evoked by single depolarizations in LEMS-treated cells closely followed the relationship between Ca2+ influx and exocytosis that was derived in control cells (Engisch and Nowycky, 1996). Similarly, in whole-cell capacitance recordings of H146 cells (a small-cell lung cancer cell line), exocytosis evoked by single long depolarizations was reduced in proportion to reductions in plateau current by either LEMS antibody treatment or exposure to omega -agatoxin IVA (Viglione et al., 1995). These results support the suggestion that the Ca2+ dependence of release is preserved in LEMS.

The hallmark of LEMS is a small CMAP that facilitates after repetitive stimulation. CMAP measures the sum of action potentials (APs) generated in the muscle by acetylcholine released during nerve stimulation. In controls the CMAP amplitude does not facilitate during repetitive stimulation, but this could be because 100% of muscle fibers are already firing APs. A more sensitive measure of presynaptic activity is the EPP. During high-frequency stimulation, EPPs decrease at normal NMJs (Elmqvist and Quastel, 1965) but increase at NMJs of LEMS patients (Elmqvist and Lambert, 1968). Facilitation is also observed at normal mammalian NMJs under conditions in which the initial response is reduced, usually by lowering [Ca2+]o and/or raising [Mg2+]o (Del Castillo and Katz, 1954). Katz and Miledi (1968) proposed the residual Ca2+ hypothesis to explain activity-dependent facilitation of transmitter release: when [Ca2+]o is low, insufficient Ca2+ ions enter during a single AP to trigger maximal release but accumulate during a train, and each successive AP triggers more release. More recent modifications of this hypothesis postulate the existence of a facilitation site that senses accumulated Ca2+, distinct from the exocytosis trigger (Kamiya and Zucker, 1994; Zucker, 1996). Because the LEMS antibodies inhibit Ca2+ currents and reduce evoked release, the abnormal facilitation in LEMS has been attributed to Ca2+ accumulation (Lambert and Elmqvist, 1971; Tim and Sanders, 1994).

Our previous data in chromaffin cells suggest that activity-dependent facilitation may be caused by more than the simple accumulation of Ca2+ ions beneath the plasma membrane. Ca2+ accumulation should be increased when pulse interval is shortened, but this manipulation prevented the development of enhancement in chromaffin cells (Engisch et al., 1997). In addition, although greater Ca2+ accumulation would be expected for trains of longer duration pulses at the same frequency, these protocols induced depression. Depression is usually attributed to vesicle depletion (Elmqvist and Quastel, 1965; Thies, 1965; Zucker, 1989). In chromaffin cells depression is not caused by depletion because it occurs after a smaller amount of exocytosis than is evoked by a single long depolarization in the same cell (Engisch et al., 1997). We concluded that in chromaffin cells, specific patterns of Ca2+ entry induce a change in the Ca2+ sensitivity of the secretory process.

Exposure of chromaffin cells to LEMS antibodies could have produced any one of the following effects on exocytosis evoked by stimulus trains. (1) If the only action of LEMS antibodies is to decrease Ca2+ entry, the likelihood of depression should decrease and that of enhancement increase, for the same stimulus parameters (duration, pulse interval); (2) decreased Ca2+ entry could result in less exocytosis during a train, as it does during single pulses; and (3) if LEMS antibodies target proteins other than Ca2+ channels, novel behaviors could occur, or depression or enhancement may be either increased or reduced beyond the effects expected for changes in Ca2+ entry.

For three protocols in cells exposed to LEMS IgGs (trains of 5, 10, or 40 msec pulses, 200 msec intervals), secretory behaviors shifted from fewer depressed responses to more enhanced responses, an effect that is expected for a simple decrease in Ca2+ entry. Enhancement in LEMS-treated cells was not caused by Ca2+ accumulation because it resembled enhancement in untreated cells, being abolished rather than increased when pulses were applied at higher frequency (K. Engisch and M. Nowycky, unpublished observations). Unusual secretory behaviors did occur in treated cells, but these were rare (~10% of all trains). The process of depression per se was not altered by the antibodies. Trains with large Ca2+ current integrals in LEMS-treated cells caused depressed responses at the expected (>90%) frequency.

Although much of the increase in the probability of activity-dependent enhancement can be explained by the ability of LEMS IgGs to inhibit Ca2+ entry, there appeared to be an additional action on enhancement for two of the five LEMS IgGs. First, the percentage of trains with enhancement was approximately double for cells treated with LEMS 3 or LEMS 4 IgGs, compared with controls within the same narrow range of low Ca2+ entry values. Second, LEMS 4 IgG increased enhancement without substantially inhibiting Ca2+ entry. In conclusion, all five LEMS antibodies increased the probability of activity-dependent enhancement in chromaffin cells. Effects of three of the antibodies could be attributed solely to a reduction in Ca2+ entry. Two of the antibodies appeared to have an additional influence on the enhancement process.

Our results suggest that a possible target of LEMS IgGs, in addition to presynaptic Ca2+ channels, is a protein or complex of proteins important for controlling activity-dependent facilitation. A key finding is that the probability of facilitation was altered by LEMS IgGs without any change in the Ca2+-exocytosis coupling during a single stimulus. This result suggests that components of the secretory machinery modify the release process but are not mandatory participants in the trigger or fusion mechanisms active during a single stimulus. Chromaffin cells are a useful model system to determine the roles of particular proteins in triggering vesicle fusion, controlling the fusion step, and modulating secretory efficacy. It remains to be determined whether the properties of activity-dependent facilitation in chromaffin cells are applicable to the NMJ or other fast synapses.


    FOOTNOTES

Received Dec. 15, 1998; revised Feb. 16, 1999; accepted Feb. 22, 1999.

This work was supported by National Institutes of Health Grant NS27781 (M.C.N.) and the Muscular Dystrophy Association (M.C.N.). K.L.E. is an Edward Jekkal Muscular Dystrophy Fellow. We thank Dr. S. Bird (University of Pennsylvania School of Medicine) for aid in obtaining patient sera, and Dr. R. Nichols (Medical College of Pennsylvania and Hahnemann University) for advice on purification of IgGs.

Correspondence should be sent to Dr. Engisch at her present address: Department of Physiology, Emory University School of Medicine, 1648 Pierce Street, Atlanta, GA 30322.

Dr. Rich's present address: Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322.

Dr. Nowycky's present address: Department of Pharmacology and Physiology, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103-2714.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

  • Artalejo CR, Ariano MA, Perlman RL, Fox AP (1990) Activation of facilitation calcium channels in chromaffin cells by D1 dopamine receptors through a cAMP/protein kinase A-dependent mechanism. Nature 348:239-242[Medline].
  • Artalejo CR, Dahmer MK, Perlman RL, Fox AP (1991a) Two types of Ca2+ currents are found in bovine chromaffin cells: facilitation is due to the recruitment of one type. J Physiol (Lond) 432:681-707[Abstract/Free Full Text].
  • Artalejo CR, Mogul DJ, Perlman RL, Fox AP (1991b) Three types of bovine chromaffin Ca2+ channels: facilitation increases the opening probability of a 27 pS channel. J Physiol (Lond) 444:213-240[Abstract/Free Full Text].
  • Blandino JK, Kim YI (1993) Lambert-Eaton syndrome IgG inhibits dihydropyridine-sensitive, slowly inactivating calcium channels in bovine adrenal chromaffin cells. Ann NY Acad Sci 681:394-397[Web of Science][Medline].
  • Blandino JKW, Viglione MP, Bradley WA, Oie HK, Kim YI (1995) Voltage-dependent sodium channels in human small-cell lung cancer cells: role in action potentials and inhibition by Lambert-Eaton syndrome IgG. J Membr Biol 143:153-163[Web of Science][Medline].
  • Burgoyne RD, Morgan A (1998) Analysis of regulated exocytosis in adrenal chromaffin cells: insights into NSF/SNAP/SNARE function. BioEssays 20:328-335[Web of Science][Medline].
  • Charvin N, Leveque C, Walker D, Berton F, Raymond C, Kataoka M, Shoji-Kasai Y, Takahashi M, De Waard M, Seagar MJ (1997) Direct interaction of the calcium sensor protein synaptotagmin I with a cytoplasmic domain of the alpha 1A subunit of the P/Q-type calcium channel. EMBO J 16:4591-4596[Web of Science][Medline].
  • Chow RH, Klingauf J, Heinemann C, Zucker RS, Neher E (1996) Mechanisms determining the time course of secretion in neuroendocrine cells. Neuron 16:369-376[Web of Science][Medline].
  • Cooke JD, Okamoto K, Quastel DMJ (1973) The role of calcium in depolarization secretion coupling at the motor nerve terminal. J Physiol (Lond) 228:459-497[Abstract/Free Full Text].
  • Cull-Candy SG, Lundh H, Thesleff S (1976) Effects of botulinum toxin on neuromuscular transmission in the rat. J Physiol (Lond) 260:177-203[Abstract/Free Full Text].
  • Cull-Candy SG, Miledi R, Trautmann A, Uchitel OD (1980) On the release of transmitter at normal, myasthenia gravis and myasthenic syndrome affected human end-plates. J Physiol (Lond) 299:621-638[Abstract/Free Full Text].
  • Del Castillo J, Katz B (1954) The effect of magnesium on the activity of motor nerve endings. J Physiol (Lond) 124:553-559.
  • Dodge FA, Rahamimoff R (1967) Cooperative action of calcium ions in transmitter release at the neuromuscular junction. J Physiol (Lond) 193:419-433[Abstract/Free Full Text].
  • Elhamdani A, Zhou Z, Artalejo CR (1998) Timing of dense-core vesicle exocytosis depends on the facilitation L-type Ca channel in adrenal chromaffin cells. J Neurosci 18:6230-6240[Abstract/Free Full Text].
  • Elmqvist D, Lambert EH (1968) Detailed analysis of neuromuscular transmission in a patient with myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clin Proc 43:689-713[Web of Science][Medline].
  • Elmqvist D, Quastel DMJ (1965) A quantitative study of end-plate potentials in isolated human muscle. J Physiol (Lond) 178:505-529[Free Full Text].
  • Engel AG (1991) Review of evidence for loss of motor nerve terminal calcium channels in Lambert-Eaton myasthenic syndrome. Ann NY Acad Sci 635:246-258[Web of Science][Medline].
  • Engisch KL, Nowycky MC (1996) Calcium dependence of large dense-cored vesicle exocytosis evoked by calcium influx in bovine adrenal chromaffin cells. J Neurosci 16:1359-1369[Abstract/Free Full Text].
  • Engisch KL, Chernevskaya NI, Nowycky MC (1997) Short-term changes in the Ca2+-exocytosis relationship during repetitive pulse protocols in bovine adrenal chromaffin cells. J Neurosci 17:9010-9025[Abstract/Free Full Text].
  • Fidler N, Fernandez JM (1989) Phase tracking: an improved phase detection technique for cell membrane capacitance measurements. Biophys J 56:1153-1162[Web of Science][Medline].
  • Fukunaga H, Engel AG, Osame M, Lambert EH (1982) Paucity and disorganization of presynaptic membrane active zones in the Lambert-Eaton myasthenic syndrome. Muscle Nerve 5:686-697[Web of Science].
  • Garcia KD, Beam KG (1996) Reduction of calcium currents by Lambert-Eaton syndrome sera: motoneurons are preferentially affected, and L-type currents are spared. J Neurosci 16:4903-4913[Abstract/Free Full Text].
  • Garcia KD, Mynlieff M, Sanders DB, Beam KG, Walrond JP (1996) Lambert-Eaton sera reduce low-voltage and high-voltage activated Ca2+ currents in murine dorsal root ganglion neurons. Proc Natl Acad Sci USA 93:9264-9269[Abstract/Free Full Text].
  • Grassi C, Magnelli V, Carabelli V, Sher E, Carbone E (1994) Inhibition of low- and high-threshold Ca2+ channels of human neuroblastoma IMR32 cells by Lambert-Eaton myasthenic syndrome (LEMS) IgGs. Neurosci Lett 181:50-56[Web of Science][Medline].
  • Hajela RK, Atchison WD (1995) The proteins synaptotagmin and syntaxin are not general targets of Lambert-Eaton myasthenic syndrome autoantibody. J Neurochem 64:1245-1251[Web of Science][Medline].
  • Horrigan FT, Bookman RJ (1993) Na channel gating charge movement is responsible for the transient capacitance increase evoked by depolarization in rat adrenal chromaffin cells. Biophys J 64:A101.
  • Hubbard JI, Jones SF, Landau EM (1968) On the mechanism by which calcium and magnesium affect the release of transmitter by nerve impulses. J Physiol (Lond) 196:75-86[Abstract/Free Full Text].
  • Johnston I, Lang B, Leys K, Newsom-Davis J (1994) Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient. Neurology 44:334-338[Abstract/Free Full Text].
  • Joshi C, Fernandez JM (1988) Capacitance measurements. An analysis of the phase detector technique used to study exocytosis and endocytosis. Biophys J 53:885-892[Web of Science][Medline].
  • Kamiya H, Zucker RS (1994) Residual Ca2+ and short-term synaptic plasticity. Nature 371:603-606[Medline].
  • Katz B, Miledi R (1968) The role of calcium in neuromuscular facilitation. J Physiol (Lond) 195:481-492[Abstract/Free Full Text].
  • Katz JS, Wolfe GI, Bryan WW, Tintner R, Barohn RJ (1998) Acetylcholine receptor antibodies in the Lambert-Eaton myasthenic syndrome. Neurology 50:470-475[Abstract].
  • Kim YI, Neher E (1988) IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels. Science 239:405-408[Abstract/Free Full Text].
  • Kimura J (1989) Electrodiagnosis. In: Diseases of nerve and muscle: principles and practice, p 107. Philadelphia: F. A. Davis.
  • Lambert EH, Elmqvist D (1971) Quantal components of end-plate potentials in the myasthenic syndrome. Ann NY Acad Sci 183:183-199[Web of Science][Medline].
  • Lang B, Newsom-Davis J, Peers C, Prior C, Wray DW (1987) The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse. J Physiol (Lond) 390:257-270[Abstract/Free Full Text].
  • Lennon VA, Kryzer TJ, Griesmann GE, O'Suilleabhain PE, Windebank AJ, Woppmann A, Miljanich GP, Lambert EH (1995) Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 332:1467-1474[Abstract/Free Full Text].
  • Leveque C, Hoshino T, David P, Shoji-Kasi Y, Leys K, Omori A, Lang B, El Far O, Sato K, Martin-Moutot N, Newsom-Davis J, Takahashi M, Seagar MJ (1992) The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen. Proc Natl Acad Sci USA 89:3625-3629[Abstract/Free Full Text].
  • Maddison P, Newsom-Davis J, Mills KR (1998) Decay of postexercise augmentation in the Lambert-Eaton myasthenic syndrome: effect of cooling. Neurology 50:1083-1087[Abstract/Free Full Text].
  • Magelby K (1987) Short-term changes in synaptic efficacy. In: Synaptic function (Edelman GM, Gall WE, Cowan WM, eds), pp 21-56. New York: Wiley.
  • Magnelli V, Grassi C, Parlatore E, Sher E, Carbone E (1996) Down-regulation of non-L-, non-N-type (Q-like) Ca2+ channels by Lambert-Eaton myasthenic syndrome (LEMS) antibodies in rat insulinoma RINm5F cells. FEBS Lett 387:47-52[Web of Science][Medline].
  • Meriney SD, Hulsizer SC, Lennon VA, Grinnell AD (1996) Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma. Ann Neurol 40:739-749[Web of Science][Medline].
  • Morgan A, Burgoyne RD (1997) Common mechanisms for regulated exocytosis in the chromaffin cell and the synapse. Semin Cell Dev Biol 8:141-149[Web of Science][Medline].
  • Motomura M, Lang B, Johnston I, Palace J, Vincent A, Newsom-Davis J (1997) Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J Neurol Sci 147:35-42[Web of Science][Medline].
  • Neher E, Marty A (1982) Discrete changes of cell membrane capacitance observed under conditions of enhanced secretion in bovine adrenal chromaffin cells. Proc Natl Acad Sci USA 79:6712-6716[Abstract/Free Full Text].
  • Pinto A, Gillard S, Moss F, Whyte K, Brust P, Williams M, Stauderman K, Harpold M, Lang B, Newsom-Davis J, Bleakman D, Lodge D, Boot J (1998) Human autoantibodies specific for the alpha 1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons. Proc Natl Acad Sci USA 95:8328-8333[Abstract/Free Full Text].
  • Protti DA, Reisin R, Angelillo Mackinley T, Uchitel OD (1996) Calcium channel blockers and transmitter release at the normal human neuromuscular junction. Neurology 46:1391-1396[Abstract/Free Full Text].
  • Randall AD (1998) The molecular basis of voltage-gated Ca2+-channel diversity: is it time for T? J Membr Biol 161:207-213[Web of Science][Medline].
  • Seward EP, Nowycky MC (1996) Kinetics of stimulus-coupled secretion in dialyzed bovine chromaffin cells in response to trains of depolarizing pulses. J Neurosci 16:553-562[Abstract/Free Full Text].
  • Sher E, Carbone E, Clementi F (1993) Neuronal calcium channels as target for Lambert-Eaton myasthenic syndrome autoantibodies. Ann NY Acad Sci 681:373-381[Web of Science][Medline].
  • Smith DO, Conklin MW, Jensen PJ, Atchison WD (1995) Decreased calcium currents in motor nerve terminals of mice with Lambert-Eaton myasthenic syndrome. J Physiol (Lond) 487:115-123[Abstract/Free Full Text].
  • Takahasi M, Arimatsu Y, Fujita S, Fujimoto Y, Kondo S, Hama T, Miyamoto E (1991) Protein kinase C and Ca2+/calmodulin-dependent protein kinase II phosphorylate a novel 58-kDa protein in synaptic vesicles. Brain Res 551:279-292[Web of Science][Medline].
  • Takamori M, Hamada T, Komai K, Takahashi M, Yoshida A (1994) Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats. Ann Neurol 35:74-80[Web of Science][Medline].
  • Takamori M, Takahashi M, Yasukawa Y, Iwasa K, Nemoto Y, Suenaga A, Nagataki S, Nakamura T (1995) Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome. J Neurol Sci 133:95-101[Web of Science][Medline].
  • Takamori M, Iwasa K, Komai K (1997) Antibodies to synthetic peptides of the alpha 1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome. Neurology 48:1261-1265[Abstract].
  • Thies RE (1965) Neuromuscular depression and the apparent depletion of transmitter in mammalian muscle. J Neurophysiol 28:427-442[Free Full Text].
  • Tim RW, Sanders DB (1994) Repetitive nerve stimulation studies in the Lambert-Eaton myasthenic syndrome. Muscle Nerve 17:995-1001[Web of Science][Medline].
  • Trifaro JM, Vitale ML, Rodriguez Del Castillo A (1993) Scinderin and chromaffin cell actin network dynamics during neurotransmitter release. J Physiol (Paris) 87:89-106[Web of Science][Medline].
  • Verschuuren JJ, Dalmau J, Tunkel R, Lang B, Graus F, Schramm L, Posner JB, Newsom-Davis J, Rosenfeld MR (1998) Antibodies against the calcium channel beta -subunit in Lambert-Eaton myasthenic syndrome. Neurology 50:475-479[Abstract].
  • Viglione MP, Creutz CE, Kim YI (1992) Lambert-Eaton syndrome: antigen-antibody interaction and calcium current inhibition in chromaffin cells. Muscle Nerve 15:1325-1333[Web of Science][Medline].
  • Viglione MP, O'Shaughnessy TJ, Kim YI (1995) Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells. J Physiol (Lond) 488:303-317[Abstract/Free Full Text].
  • Vincent A, Lang B, Newsom-Davis J (1989) Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder. Trends Neurosci 12:496-502[Web of Science][Medline].
  • Vitale M, Rodriguez del Castillo A, Tchakarov L, Trifaro J-M (1991) Cortical filamentous actin disassembly and scinderin redistribution during chromaffin cell stimulation precede exocytosis, a phenomenon not exhibited by gelsolin. J Cell Biol 113:1057-1067[Abstract/Free Full Text].
  • Yoshida A, Oho C, Omori A, Kuwahara R, Ito T, Takahashi M (1992) HPC-1 is associated with synaptotagmin and omega -conotoxin receptor. J Biol Chem 267:24925-24928[Abstract/Free Full Text].
  • Zucker RS (1989) Short-term synaptic plasticity. Annu Rev Neurosci 12:13-31[Web of Science][Medline].
  • Zucker RS (1996) Exocytosis: a molecular and physiological perspective. Neuron 17:1049-1055[Web of Science][Medline].


Copyright © 1999 Society for Neuroscience  0270-6474/99/1993384-12$05.00/0


This article has been cited by other articles:


Home page
NeuroscientistHome page
M. M. Rich
The Control of Neuromuscular Transmission in Health and Disease
Neuroscientist, April 1, 2006; 12(2): 134 - 142.
[Abstract] [PDF]


Home page
J. Neurophysiol.Home page
R. Thiagarajan, J. Wilhelm, T. Tewolde, Y. Li, M. M. Rich, and K. L. Engisch
Enhancement of Asynchronous and Train-Evoked Exocytosis in Bovine Adrenal Chromaffin Cells Infected With a Replication Deficient Adenovirus
J Neurophysiol, November 1, 2005; 94(5): 3278 - 3291.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
R. Thiagarajan, T. Tewolde, Y. Li, P. L. Becker, M. M. Rich, and K. L. Engisch
Rab3A negatively regulates activity-dependent modulation of exocytosis in bovine adrenal chromaffin cells
J. Physiol., March 1, 2004; 555(2): 439 - 457.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
R. M. Smith, B. Baibakov, Y. Ikebuchi, B. H. White, N. A. Lambert, L. K. Kaczmarek, and S. S. Vogel
Exocytotic Insertion of Calcium Channels Constrains Compensatory Endocytosis to Sites of Exocytosis
J. Cell Biol., February 21, 2000; 148(4): 755 - 768.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engisch, K. L.
Right arrow Articles by Nowycky, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engisch, K. L.
Right arrow Articles by Nowycky, M. C.

-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-